Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis

This study has been completed.

Sponsor:

University Hospital, Lille

ClinicalTrials.gov Identifier:

NCT01415219

First Posted: August 11, 2011

Last Update Posted: December 18, 2014

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

A program of 12 individual exercise sessions (3 per week during 4 weeks)

Other: Active rehabilitation

A program of 12 individual exercise sessions (3 per week during 4 weeks)

No Intervention: conventional care

community based physiotherapy

Detailed Description:

Dermatomyositis (DM) and polymyositis (PM) are inflammatory disabling neuromuscular disorders. Despite partial benefit of pharmacological treatments, muscle strength, functional status and quality of life remain impaired. Although the use muscle exercises in (DM) and (PM) have been reported, its efficacy on disability and quality of life has not been proved.

Te aim of the study is to evaluate the benefit at mid term (12 months) of an active rehabilitation program administrated to patients affected by PM and DM.

Method: a 3 year prospective, multicentric, randomized controlled trial A program of 12 individual exercise sessions (3 per week during 4 weeks) is compared to conventional care. Patients are followed 12 month after the inclusion.

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

18 Years to 65 Years (Adult)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

diagnosis of Dermatomyositis ore polymyositis according to the International Myositis Assessment and Clinical Studies Group

functional impairment (an HAQ score greater than 0.5)

stability of muscle impairment

medical insurance

Exclusion Criteria:

no recent inflammatory activity

other chronic disease

cognitive impairment

patients who participated to a rehabilitation program before inclusion

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01415219